[Chronic obstructive pulmonary disease exacerbation. Do we use all possibilities of outpatient therapy?].
Chronic obstructive pulmonary disease (COPD) exacerbations are evaluated from a history of the disease, its clinical symptoms, and laboratory tests. The most common causes of a COPD exacerbation are upper respiratory tract and tracheobronchial infections. The exacerbation severity usually corresponds to the magnitude of clinical manifestations of COPD during its stable course. Successful treatment in patients with a COPD exacerbation is determined by its timely diagnosis. When treating patients with a mild or moderate exacerbation of Stages I-II COPD in an outpatient setting, it is advisable to use ascoril having broncholytic, mucolytic, and mucokinetic properties along with antibiotics and glucocorticosteroids, if clinically indicated.
I V
IV
Leshchenko
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D005100:Expectorants / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D010045:Outpatients; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D001993:Bronchodilator Agents; D005100:Expectorants; D005938:Glucocorticoids